was read the article
array:24 [ "pii" => "S234128791630120X" "issn" => "23412879" "doi" => "10.1016/j.anpede.2016.10.003" "estado" => "S300" "fechaPublicacion" => "2016-12-01" "aid" => "2059" "copyright" => "Asociación Española de Pediatría" "copyrightAnyo" => "2015" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2016;85:284-90" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1527 "formatos" => array:3 [ "EPUB" => 123 "HTML" => 1005 "PDF" => 399 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1695403316000400" "issn" => "16954033" "doi" => "10.1016/j.anpedi.2016.02.002" "estado" => "S300" "fechaPublicacion" => "2016-12-01" "aid" => "2059" "copyright" => "Asociación Española de Pediatría" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2016;85:284-90" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 4490 "formatos" => array:3 [ "EPUB" => 138 "HTML" => 2935 "PDF" => 1417 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">ORIGINAL</span>" "titulo" => "Asociación de valores elevados de péptido natriurético auricular y copeptina con riesgo de mortalidad" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "284" "paginaFinal" => "290" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "High levels of atrial natriuretic peptide and copeptin and mortality risk" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figura 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1533 "Ancho" => 1545 "Tamanyo" => 114019 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Comparación de los niveles plasmáticos de RM-proPNA, copeptina y PCT en los grupos 1 (número de órganos en fallo mayor de 1) y 2 (número de órganos en fallo menor de 2). p menor de 0,001 para los 3 marcadores.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Corsino Rey, Clara García-Cendón, Pablo Martínez-Camblor, Jesús López-Herce, Andrés Concha-Torre, Alberto Medina, Ana Vivanco-Allende, Juan Mayordomo-Colunga" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Corsino" "apellidos" => "Rey" ] 1 => array:2 [ "nombre" => "Clara" "apellidos" => "García-Cendón" ] 2 => array:2 [ "nombre" => "Pablo" "apellidos" => "Martínez-Camblor" ] 3 => array:2 [ "nombre" => "Jesús" "apellidos" => "López-Herce" ] 4 => array:2 [ "nombre" => "Andrés" "apellidos" => "Concha-Torre" ] 5 => array:2 [ "nombre" => "Alberto" "apellidos" => "Medina" ] 6 => array:2 [ "nombre" => "Ana" "apellidos" => "Vivanco-Allende" ] 7 => array:2 [ "nombre" => "Juan" "apellidos" => "Mayordomo-Colunga" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S234128791630120X" "doi" => "10.1016/j.anpede.2016.10.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S234128791630120X?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403316000400?idApp=UINPBA00005H" "url" => "/16954033/0000008500000006/v1_201611301127/S1695403316000400/v1_201611301127/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2341287916301211" "issn" => "23412879" "doi" => "10.1016/j.anpede.2016.10.004" "estado" => "S300" "fechaPublicacion" => "2016-12-01" "aid" => "2127" "copyright" => "Asociación Española de Pediatría" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2016;85:291-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1778 "formatos" => array:3 [ "EPUB" => 127 "HTML" => 1094 "PDF" => 557 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Reduction in necrotising enterocolitis after implementing an evidence-based enteral nutrition protocol in very low birth weight newborns" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "291" "paginaFinal" => "299" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Reducción de la enterocolitis necrosante tras la introducción de un protocolo de alimentación enteral basado en la evidencia en recién nacidos de muy bajo peso" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Tomás Sánchez-Tamayo, María Gracia Espinosa Fernández, Laura Affumicato, María González López, Verónica Fernández Romero, María Concepción Moreno Algarra, Enrique Salguero García" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Tomás" "apellidos" => "Sánchez-Tamayo" ] 1 => array:2 [ "nombre" => "María Gracia" "apellidos" => "Espinosa Fernández" ] 2 => array:2 [ "nombre" => "Laura" "apellidos" => "Affumicato" ] 3 => array:2 [ "nombre" => "María" "apellidos" => "González López" ] 4 => array:2 [ "nombre" => "Verónica" "apellidos" => "Fernández Romero" ] 5 => array:2 [ "nombre" => "María Concepción" "apellidos" => "Moreno Algarra" ] 6 => array:2 [ "nombre" => "Enrique" "apellidos" => "Salguero García" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1695403316302168" "doi" => "10.1016/j.anpedi.2016.06.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403316302168?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287916301211?idApp=UINPBA00005H" "url" => "/23412879/0000008500000006/v1_201611291247/S2341287916301211/v1_201611291247/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2341287916301193" "issn" => "23412879" "doi" => "10.1016/j.anpede.2016.10.002" "estado" => "S300" "fechaPublicacion" => "2016-12-01" "aid" => "2165" "copyright" => "Asociación Española de Pediatría" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "An Pediatr (Barc). 2016;85:281-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2282 "formatos" => array:3 [ "EPUB" => 133 "HTML" => 1597 "PDF" => 552 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Tuberculosis in children. Challenges and opportunities" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "281" "paginaFinal" => "283" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tuberculosis en niños. Retos y oportunidades" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jose A. Caminero, Anna Scardigli" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Jose A." "apellidos" => "Caminero" ] 1 => array:2 [ "nombre" => "Anna" "apellidos" => "Scardigli" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1695403316302727" "doi" => "10.1016/j.anpedi.2016.09.012" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403316302727?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287916301193?idApp=UINPBA00005H" "url" => "/23412879/0000008500000006/v1_201611291247/S2341287916301193/v1_201611291247/en/main.assets" ] "en" => array:21 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "High levels of atrial natriuretic peptide and copeptin and mortality risk" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "284" "paginaFinal" => "290" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Corsino Rey, Clara García-Cendón, Pablo Martínez-Camblor, Jesús López-Herce, Andrés Concha-Torre, Alberto Medina, Ana Vivanco-Allende, Juan Mayordomo-Colunga" "autores" => array:8 [ 0 => array:4 [ "nombre" => "Corsino" "apellidos" => "Rey" "email" => array:2 [ 0 => "crey@uniovi.es" 1 => "corsino.rey@sespa.princast.es" ] "referencia" => array:4 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 3 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Clara" "apellidos" => "García-Cendón" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 2 => array:3 [ "nombre" => "Pablo" "apellidos" => "Martínez-Camblor" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 3 => array:3 [ "nombre" => "Jesús" "apellidos" => "López-Herce" "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">h</span>" "identificador" => "aff0040" ] ] ] 4 => array:3 [ "nombre" => "Andrés" "apellidos" => "Concha-Torre" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 5 => array:3 [ "nombre" => "Alberto" "apellidos" => "Medina" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 6 => array:3 [ "nombre" => "Ana" "apellidos" => "Vivanco-Allende" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 7 => array:3 [ "nombre" => "Juan" "apellidos" => "Mayordomo-Colunga" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:8 [ 0 => array:3 [ "entidad" => "Unidad de Cuidados Intensivos Pediátricos, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Universidad de Oviedo, Oviedo, Asturias, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Red SAMID II, Instituto de Salud Carlos III, Madrid, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Centro de Salud de Tomiño, Servicio Gallego de Salud, Tomiño, Pontevedra, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Universidad Autónoma de Chile, Santiago, Chile" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Servicio de Cuidados Intensivos Pediátricos, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain" "etiqueta" => "g" "identificador" => "aff0035" ] 7 => array:3 [ "entidad" => "Universidad Complutense, Madrid, Spain" "etiqueta" => "h" "identificador" => "aff0040" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Asociación de valores elevados de péptido natriurético auricular y copeptina con riesgo de mortalidad" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1533 "Ancho" => 1545 "Tamanyo" => 113177 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Comparison of serum levels of MR-proANP, copeptin and PCT in groups A (higher scores in the risk of mortality scales) and B (lower score in the risk of mortality scales). <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.001 for all three markers.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Determining the prognosis of a critically ill child within 12<span class="elsevierStyleHsp" style=""></span>h from admission in the paediatric intensive care unit (PICU) continues to be a clinical challenge. At present, the tools used most frequently to assess risk of mortality are scales based on clinical signs and routine laboratory tests. The abnormalities found in different sections of these scales give rise to a score that correlates to mortality in patients. The scales used most frequently are the Paediatric Risk of Mortality III (PRISM III) and the Paediatric Index of Mortality 2 (PIM 2).<a class="elsevierStyleCrossRefs" href="#bib0200"><span class="elsevierStyleSup">1–5</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">In recent years, it has been demonstrated that there are biomarkers whose plasma levels increase in relation to disease severity. Procalcitonin (PCT) emerged as a marker of sepsis<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">6</span></a> and later on was found to be helpful in determining disease severity and predicting patient outcomes.<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">7</span></a> Procalcitonin could help identify children at a higher risk of mortality.<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">8</span></a> There is also evidence that atrial natriuretic peptide (ANP) and copeptin are associated with severity in septic patients and mortality in critically ill adults.<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">9–16</span></a> The secretion of ANP is primarily determined by increases in atrial wall tension,<a class="elsevierStyleCrossRef" href="#bib0280"><span class="elsevierStyleSup">17</span></a> and it modulates the permeability of the endothelium, acting on the regulation of blood volume and arterial pressure.<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">18</span></a> Arginine vasopressin (AVP) is secreted in response to osmotic or haemodynamic stimuli. Copeptin is the C-terminal portion of provasopressin.<a class="elsevierStyleCrossRefs" href="#bib0290"><span class="elsevierStyleSup">19–21</span></a> It has been regarded as an individual marker of the stress response<a class="elsevierStyleCrossRef" href="#bib0305"><span class="elsevierStyleSup">22</span></a> that is elevated during systemic infections.<a class="elsevierStyleCrossRef" href="#bib0310"><span class="elsevierStyleSup">23</span></a> Its levels have been associated with mortality risk in adult patients.<a class="elsevierStyleCrossRefs" href="#bib0260"><span class="elsevierStyleSup">13,24,25</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Laboratory tests for measuring the levels of midregional pro-ANP (MR-proANP) and copeptin have recently become available. These peptides are synthesised from ANP and AVP, respectively, but they offer the advantage of having a longer half-life (ANP, 5–10<span class="elsevierStyleHsp" style=""></span>min vs MR-proANP, 100–120<span class="elsevierStyleHsp" style=""></span>min; AVP, 5–10<span class="elsevierStyleHsp" style=""></span>min vs copeptin, ex vivo, several days), which makes them more suitable for everyday clinical practice.<a class="elsevierStyleCrossRefs" href="#bib0245"><span class="elsevierStyleSup">10,17,26</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">We thought it would be interesting to learn whether the association described in adults is also found in children, as thus far no data have been published on the association of these markers with an increased risk of mortality in paediatric patients. Thus, the aim of our study was to determine the levels of MR-proANP, copeptin and PCT in the first 12<span class="elsevierStyleHsp" style=""></span>h following admission to the PICU to test the hypothesis that elevated levels of these markers could be associated with an increased risk of mortality. A secondary objective was to evaluate the hypothesis that elevated levels of these markers would correlate to a greater number of organ system failures.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Patients and methods</span><p id="par0025" class="elsevierStylePara elsevierViewall">We conducted an observational study in two university hospital PICUs. The study was evaluated and approved by the Research Ethics Committee of the Hospital Universitario Central de Asturias. We obtained the informed consent of all parents and participants aged more than 12 years. The sample consisted of 254 patients aged less than 19 years. Newborns were excluded. Inclusion in the study required collection of a blood sample on the basis of clinical manifestations in the first 12<span class="elsevierStyleHsp" style=""></span>h from admission, and signing of the informed consent form. We collected data for the following variables: age, weight, reason for admission to the PICU, diagnosis and previous history of disease. Respiratory rate, heart rate, blood pressure, oxygen saturation, urine output and the administration of vasopressor agents were recorded every hour. Radiologic and microbiological diagnostic tests were performed as deemed necessary by the physician in charge. Blood samples for culture were collected when infection was suspected based on the clinical manifestations or the patient had a body temperature greater than 38<span class="elsevierStyleHsp" style=""></span>°C. The PIM 2 score was calculated at admission and the PRISM III within 12<span class="elsevierStyleHsp" style=""></span>h from admission, as is customary in clinical practice. Both scales (PIM 2 and PRISM III) had been previously validated in both PICUs.<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">1</span></a> Samples for routine metabolic tests, including PCT levels, were collected within 12<span class="elsevierStyleHsp" style=""></span>h from admission to the PICU. Samples of venous blood were collected in tubes containing ethylenediaminetetraacetic acid (EDTA). Plasma aliquots were frozen at −80<span class="elsevierStyleHsp" style=""></span>°C for future measurement of MR-proANP and copeptin.</p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Groups by risk of mortality</span><p id="par0030" class="elsevierStylePara elsevierViewall">Patients were divided into two groups based on their mortality risk scores. The group with a high risk of mortality (group A) included patients with PIM 2 and PRISM III scores above the 75th percentile (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>33); the group with a low risk of mortality (group B) included patients with a PIM 2 and/or PRISM III at or below the 75th percentile (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>221).</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Groups by number of organ system failures</span><p id="par0035" class="elsevierStylePara elsevierViewall">Patients were divided into two groups based on the number of organ system failures (cardiovascular, respiratory, neurologic, haematologic, renal and hepatic) following consensus criteria.<a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">27</span></a> Group 1 included patients with more than one organ system failure (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>71), while group 2 included patients with fewer than two organ system failures (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>183).</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Biochemical analysis of the midregion of the proatrial natriuretic peptide and copeptin</span><p id="par0040" class="elsevierStylePara elsevierViewall">Levels of MR-proANP, copeptin and PCT were measured in plasma with EDTA using a sandwich immunoassay technique (TRACE technology; Brahms GmbH, Hennigsdorf, Germany). The detection limits were 4.3<span class="elsevierStyleHsp" style=""></span>pmol/L for MR-proANP, 4.8<span class="elsevierStyleHsp" style=""></span>pmol/L for copeptin and 0.02<span class="elsevierStyleHsp" style=""></span>ng/mL for PCT.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Statistical analysis</span><p id="par0045" class="elsevierStylePara elsevierViewall">We summarised the clinical characteristics of patients and biomarker values as frequencies, percentages, medians and ranges. For the comparisons of two groups of patients (A vs B and 1 vs 2), we used the Mann–Whitney <span class="elsevierStyleItalic">U</span> test for continuous variables and the chi-square test for categorical variables. We also calculated the diagnostic yield (receiving operating characteristics [ROC]) curves and their respective areas under the curve (AUCs) for a confidence interval (CI) of 95%. Subsequently, we compared them with the aim of determining the marker with the highest yield for the prediction of mortality risk and of organ system failure. In order to compensate for the loss of data in paired comparisons, we used a bootstrap algorithm<a class="elsevierStyleCrossRef" href="#bib0335"><span class="elsevierStyleSup">28</span></a> to compare the AUCs. We used the Youden index to establish the cut-off point with the highest sensitivity and specificity for differentiating between the different groups (A vs B, and 1 vs 2). <span class="elsevierStyleItalic">P</span> values of less than 0.05 were considered statistically significant.</p></span></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Results</span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Sample characteristics</span><p id="par0050" class="elsevierStylePara elsevierViewall">We included 254 patients in the study (150 male). <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a> summarises their demographic, clinical and laboratory testing characteristics. More than half of the sample was aged less than 4 years. The most frequent reasons for admission were postoperative care, heart surgery, respiratory disease and infectious disease. A total of five patients (2%) died during their stay in the PICU. These five patients were in the group with a high predicted risk of mortality (group A). Patients in group A were younger than patients in group B.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0055" class="elsevierStylePara elsevierViewall">Plasma levels of MR-proANP, copeptin and PCT were significantly higher in the group of patients with a higher risk of mortality (group A) (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). MR-proANP, copeptin and PCT values were significantly higher in patients with more than one organ system failure (group 1) (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Usefulness of midregion proatrial natriuretic peptide, copeptin and procalcitonin for predicting mortality risk in paediatric intensive care units</span><p id="par0060" class="elsevierStylePara elsevierViewall">To assess the usefulness of MR-proANP, copeptin and PCT in predicting death and assessing risk of mortality in the PICU, we analysed the ROC curve for each of these biomarkers (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>). We did not find statistically significant differences between the AUCs of the three biomarkers. Levels of MR-proANP greater than 106<span class="elsevierStyleHsp" style=""></span>pmol/L had a sensitivity of 72% and a specificity of 70%, while levels of copeptin greater than 64<span class="elsevierStyleHsp" style=""></span>pmol/L had a sensitivity of 70% and a specificity of 74%. The optimal cut-off point for PCT to predict risk of mortality was 2<span class="elsevierStyleHsp" style=""></span>ng/mL, with a sensitivity and specificity of 80%.</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Usefulness of midregion proatrial natriuretic peptide, copeptin and procalcitonin for predicting the number of organ system failures</span><p id="par0065" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#fig0020">Fig. 4</a> shows the ROC curves for each biomarker. We found significant differences in the AUCs between MR-proANP and copeptin (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.01). Differences in the AUCs were not significant in the comparisons between MR-proANP and PCT (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.48) and between PCT and copeptin (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.21). Levels of de MR-proANP greater than 101<span class="elsevierStyleHsp" style=""></span>pmol/L had a sensitivity and specificity of 77%, while levels of copeptin greater than 64<span class="elsevierStyleHsp" style=""></span>pmol/L had a sensitivity of 62% and a specificity of 80%. A PCT threshold of 4.1<span class="elsevierStyleHsp" style=""></span>ng/mL had a sensitivity of 69% and a specificity of 88%.</p><elsevierMultimedia ident="fig0020"></elsevierMultimedia></span></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Discussion</span><p id="par0070" class="elsevierStylePara elsevierViewall">Improving the assessment of the prognosis of patients admitted to the PICU is a field of research relevant to clinical practice. Some biomarkers could help stratify critically ill children based on their risk of mortality.<a class="elsevierStyleCrossRefs" href="#bib0200"><span class="elsevierStyleSup">1,8</span></a> In our study of a heterogeneous sample of critically ill children, elevated levels of MR-proANP, copeptin and PCT were associated with higher scores in mortality risk scales and a greater number of organ system failures.</p><p id="par0075" class="elsevierStylePara elsevierViewall">The low mortality in our sample, which was similar to the rates currently reported for PICUs in developed countries, forced us to use mortality risk scores obtained using scales previously validated in our PICUs<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">1</span></a> as the reference for the prediction of patient prognosis. This will hinder the comparison of our results with those obtained in the adult population, although it is worth noting that all patients that died belonged to the group with high mortality risk scores. The low mortality also led us to use a second severity marker, organ failure, as a reference. More than 90% of patients in the high-mortality risk group had experienced at least two organ system failures.</p><p id="par0080" class="elsevierStylePara elsevierViewall">To date, few data are available on the potential of MR-proANP as a predictor of mortality risk, especially in the paediatric population. It has been investigated as a marker of severity in adult septic patients with promising results.<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">9</span></a> Elevated levels of MR-proANP at admission in critically ill patients have been associated with higher mortality.<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">9–11</span></a> In our study, we found an AUC of 0.76 for the identification of critically ill children with different predicted mortality risks. Different AUCs have been found in various studies in relation to the risk of mortality: 0.72 in the studies by Lipinska et al.<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">10</span></a> and Nowak et al.<a class="elsevierStyleCrossRef" href="#bib0255"><span class="elsevierStyleSup">12</span></a> 0.88 in the study by Morgenthaler et al.<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">9</span></a> and 0.89 in the study by Wang et al.<a class="elsevierStyleCrossRef" href="#bib0340"><span class="elsevierStyleSup">29</span></a> Our cut-off point of 106<span class="elsevierStyleHsp" style=""></span>pmol/L was lower than the cut-off points estimated in these adult series. This could be due to these studies having been performed with patients with different characteristics than the patients in our study, and with different methods. We studied a cohort of children and sought to differentiate the predicted mortality risk at the level of the 75th percentile, whereas the studies that we reviewed<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">9,11,12,29,30</span></a> analysed adult populations and sought to differentiate between survivors and nonsurvivors. The study of Lipinska et al.<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">10</span></a> only included patients with sepsis. Another study carried out in adults by Berendes et al.<a class="elsevierStyleCrossRef" href="#bib0350"><span class="elsevierStyleSup">31</span></a> did not find an association between different levels of MR-proANP and the risk of mortality.</p><p id="par0085" class="elsevierStylePara elsevierViewall">As for copeptin, studies on adults have found areas under ROC curves ranging from 0.70 (Seligman et al.<a class="elsevierStyleCrossRef" href="#bib0355"><span class="elsevierStyleSup">32</span></a>) to 0.87 (Du et al.<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">14</span></a>), with intermediate values of 0.75 reported by Morgenthaler et al.<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">13</span></a> and of 0.83 by Lin et al.<a class="elsevierStyleCrossRef" href="#bib0360"><span class="elsevierStyleSup">33</span></a> Our AUC of 0.73 is within this range. We determined a cut-off point of 64<span class="elsevierStyleHsp" style=""></span>pmol/L, similar to those of 64.8 and 62.7<span class="elsevierStyleHsp" style=""></span>pmol/L by Seligman et al.<a class="elsevierStyleCrossRef" href="#bib0355"><span class="elsevierStyleSup">32</span></a> and Du et al.<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">14</span></a> respectively. Lin et al.<a class="elsevierStyleCrossRef" href="#bib0360"><span class="elsevierStyleSup">33</span></a> estimated a cut-off point of 52.7<span class="elsevierStyleHsp" style=""></span>pmol/L, slightly below those reported in other studies. The AUC for high PCT values is also acceptable for predicting mortality risk, and it is known that PCT levels are directly correlated to severity of disease.<a class="elsevierStyleCrossRefs" href="#bib0230"><span class="elsevierStyleSup">7,34–36</span></a></p><p id="par0090" class="elsevierStylePara elsevierViewall">As expected, the yield of MR-proANP, copeptin and PCT in identifying patients with more than one organ system failure was consistent with previous descriptions of the prediction of mortality risk in the literature. The values of the AUCs for the differentiation between groups 1 and 2 were acceptable for copeptin and good for PCT and MR-proANP (<a class="elsevierStyleCrossRef" href="#fig0020">Fig. 4</a>). For PCT, this cut-off value (4.1<span class="elsevierStyleHsp" style=""></span>ng/mL) was higher than the cut-off value for the prediction of mortality risk (2.0<span class="elsevierStyleHsp" style=""></span>ng/mL), while the cut-off points for MR-proANP and copeptin were similar for both predictions. Several studies have found an association between PCT elevation in the first 24<span class="elsevierStyleHsp" style=""></span>h of admission<a class="elsevierStyleCrossRef" href="#bib0380"><span class="elsevierStyleSup">37</span></a> or following surgery<a class="elsevierStyleCrossRef" href="#bib0385"><span class="elsevierStyleSup">38</span></a> and the number of organ system failures. Lipinska et al.<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">10</span></a> and Boeck et al.<a class="elsevierStyleCrossRef" href="#bib0250"><span class="elsevierStyleSup">11</span></a> demonstrated the correlation between the levels of MR-proANP and the Sequential Organ Failure Assessment score. We did not find any studies that analysed the use of copeptin as a marker of multiple organ failure. In short, the information provided by these markers could improve the identification of patients with higher scores in mortality risk scales and more than one organ system failure.</p><p id="par0095" class="elsevierStylePara elsevierViewall">The PRISM III and PIM 2 scales have been validated for the stratification of mortality risk, but are used more frequently in health administration and research than in clinical decision-making.<a class="elsevierStyleCrossRefs" href="#bib0200"><span class="elsevierStyleSup">1,3,5</span></a> Therefore, it would be helpful to have a biomarker that can be measured rapidly and provide similar information. Our group previously observed in the same cohort of patients<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">8</span></a> that the midregion of proadrenomedullin (MR-proADM) could also be used to predict the risk of mortality (AUC, 0.866; 95% CI: 0.810–0.921) and the number of organ system failures (AUC, 0.922; 95% CI: 0.887–0.957). When we compared the AUCs, we found statistically significant differences between MR-proADM and MR-proANP (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.05), and between MR-proADM and copeptin (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.01). Thus, in our cohort MR-proADM had a higher predictive power than MR-proANP and copeptin. Several recent studies have also shown that MR-proADM levels could be good markers of severity in critically ill patients, both in children<a class="elsevierStyleCrossRefs" href="#bib0235"><span class="elsevierStyleSup">8,39</span></a> and adults.<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">13</span></a> To confirm our results, future studies should assess whether RM-proADM is a better prognostic predictor than the other three markers.</p><p id="par0100" class="elsevierStylePara elsevierViewall">There are several limitations to our study. First of all, we could not use mortality as the reference for differentiating patient prognoses because mortality was low in our sample. As an alternative, we used mortality risk scales and the number of organ system failures, while remaining aware of their limitations. Secondly, we conducted an observational study that did not allow us to draw conclusions regarding therapeutic interventions. Thirdly, our results may not be representative of other PICUs in Spain or other countries, as the sample consisted of patients from only two PICUs. The predictive power could be different for a different population. Last of all, biomarkers were analysed within 12<span class="elsevierStyleHsp" style=""></span>h from admission to the PICU. Repeated measurement of biomarker levels in the early days of admission could increase their accuracy.</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Conclusion</span><p id="par0105" class="elsevierStylePara elsevierViewall">Elevated levels of MR-proANP, copeptin and PCT are associated with higher mortality risk scores. There are no significant differences between these three markers. We found that MR-proANP had a stronger correlation with the number of organ system failures than copeptin.</p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Funding</span><p id="par0110" class="elsevierStylePara elsevierViewall">This study was partially funded by a grant from the <span class="elsevierStyleGrantSponsor" id="gs1">Fundación Ernesto Sánchez Villares</span>. The kits for the determination of MR-proANP and copeptin were provided by Brahms GmbH (Hennigsdorf, Germany).</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Conflicts of interest</span><p id="par0115" class="elsevierStylePara elsevierViewall">Corsino Rey has received funds from <span class="elsevierStyleGrantSponsor" id="gs2">Brahms and Thermofisher</span> to give presentations in conferences on subjects related to biomarkers and sepsis. The rest of the authors have no conflicts of interest to declare. The Fundación Ernesto Sánchez Villares and the Brahms and Thermofisher corporations did not participate in any way in the development of the article, including the study design, data collection and analysis, writing, and decision to submit for publication.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:12 [ 0 => array:3 [ "identificador" => "xres763791" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Objective" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec765174" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres763792" "titulo" => "Resumen" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Objetivo" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec765173" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Patients and methods" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Groups by risk of mortality" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Groups by number of organ system failures" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Biochemical analysis of the midregion of the proatrial natriuretic peptide and copeptin" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Statistical analysis" ] ] ] 6 => array:3 [ "identificador" => "sec0035" "titulo" => "Results" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0040" "titulo" => "Sample characteristics" ] 1 => array:2 [ "identificador" => "sec0045" "titulo" => "Usefulness of midregion proatrial natriuretic peptide, copeptin and procalcitonin for predicting mortality risk in paediatric intensive care units" ] 2 => array:2 [ "identificador" => "sec0050" "titulo" => "Usefulness of midregion proatrial natriuretic peptide, copeptin and procalcitonin for predicting the number of organ system failures" ] ] ] 7 => array:2 [ "identificador" => "sec0055" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0060" "titulo" => "Conclusion" ] 9 => array:2 [ "identificador" => "sec0065" "titulo" => "Funding" ] 10 => array:2 [ "identificador" => "sec0070" "titulo" => "Conflicts of interest" ] 11 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2015-12-23" "fechaAceptado" => "2016-02-03" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec765174" "palabras" => array:7 [ 0 => "Mortality risk" 1 => "Organ failure" 2 => "Prognosis" 3 => "Atrial natriuretic peptide" 4 => "Copeptin" 5 => "Procalcitonin" 6 => "Critically ill children" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec765173" "palabras" => array:7 [ 0 => "Riesgo de mortalidad" 1 => "Fallo de órganos" 2 => "Pronóstico" 3 => "Péptido natriurético auricular" 4 => "Copeptina" 5 => "Procalcitonina" 6 => "Niños críticamente enfermos" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Objective</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">To determine whether high levels of mid-regional pro-atrial natriuretic peptide (MR-proANP), copeptin, and procalcitonin (PCT) plasma concentrations are associated with increased mortality risk.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Prospective observational study including 254 critically ill children. MR-proANP, copeptin and PCT were compared between children with high (Group A; <span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>33) and low (Group B; <span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>221) mortality risk, and between patients with failure of more than 1 organ (Group 1; <span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>71) and less than 2 (Group 2; <span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>183).</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Median (range) of MR-proANP, copeptin, and PCT levels in group A vs B were, respectively: 209.4 (30.5–1415.8) vs. 75.0 (14.6–867.2)<span class="elsevierStyleHsp" style=""></span>pmol/L (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.001); 104.4 (7.4–460.9) vs. 26.6 (0.00–613.1)<span class="elsevierStyleHsp" style=""></span>pmol/L <span class="elsevierStyleItalic">(P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.001), and 7.8 (0.3–552.0) vs. 0.3 (0.02–107.0)<span class="elsevierStyleHsp" style=""></span>ng/mL <span class="elsevierStyleItalic">(P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.001). The area under the curve (AUC) for the differentiation of group A and B was 0.764 (95% CI: 0.674–0.854) for MR-proANP; 0.735 (0.642–0.827) for copeptin, and 0.842 (0.744–0.941) for PCT, with no statistical differences. The AUCs for the differentiation of group 1 and 2 were: 0.837 (0.784–0.891) for MR-proANP, 0.735 (0.666–0.804) for copeptin, and 0.804 (0.715–0.892) for PCT, with statistical differences between MR-proANP and copeptin, <span class="elsevierStyleItalic">P</span>=.01.</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">High levels of MR-proANP, copeptin and PCT were associated with increased mortality risk scores. MR-proANP showed a higher association than copeptin with number of organs in failure.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Objective" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Objetivo</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Determinar si los niveles plasmáticos de región media del péptido natriurético proauricular (RM-proPNA), copeptina y procalcitonina (PCT) se asocian con aumento del riesgo de mortalidad.</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Métodos</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Estudio prospectivo observacional que incluyó a 254 niños críticamente enfermos. Se compararon los niveles de RM-proPNA, copeptina y PCT entre niños con alto (grupo A; n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>33) y bajo (grupo B; n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>221) riesgo de mortalidad y entre pacientes con un número de órganos en fallo mayor de 1 (grupo 1; n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>71) y menor de 2 (grupo 2; n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>183).</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Las medianas (rangos) de RM-proPNA, copeptina y PCT en grupo A vs. grupo B fueron, respectivamente: 209,4 (30,5-1.415,8) vs. 75,0 (14,6-867,2) pmol/l (p<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0,001); 104,4 (7,4-460,9) vs. 26,6 (0,00-613,1) pmol/l (p<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0,001) y 7,8 (0,3-552,0) vs. 0,3 (0,02-107,0) ng/ml (p<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0,001). El área bajo la curva (AUC) para diferenciar grupo A y B fue (intervalo de confianza del 95%): 0,764 (0,674-0,854) para RM-proPNA; 0,735 (0,642-0,827) para copeptina y 0,842 (0,744-0,941) para PCT, sin diferencias significativas. Las AUC para diferenciar los grupos 1 y 2 fueron: 0,837 (0,784-0,891) para RM-proPNA, 0,735 (0,666-0,804) para copeptina y 0,804 (0,715-0,892) para PCT, con diferencias significativas entre RM-proPNA y copeptina, p<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0,01.</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclusiones</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Los niveles elevados de RM-proPNA, copeptina y PCT se asocian con aumento de las puntuaciones de riesgo de mortalidad. RM-proPNA mostró mayor asociación que la copeptina con el número de órganos en fallo.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Objetivo" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusiones" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Rey C, García-Cendón C, Martínez-Camblor P, López-Herce J, Concha-Torre A, Medina A, et al. Asociación de valores elevados de péptido natriurético auricular y copeptina con riesgo de mortalidad. An Pediatr (Barc). 2016;85:284–290.</p>" ] ] "multimedia" => array:5 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1533 "Ancho" => 1545 "Tamanyo" => 113177 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Comparison of serum levels of MR-proANP, copeptin and PCT in groups A (higher scores in the risk of mortality scales) and B (lower score in the risk of mortality scales). <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.001 for all three markers.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1533 "Ancho" => 1545 "Tamanyo" => 113459 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Comparison of serum levels of MR-proANP, copeptin and PCT in groups 1 (number of organ system failures<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>1) and 2 (number of organ system failures<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>2). <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.001 for all three markers.</p>" ] ] 2 => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1596 "Ancho" => 1461 "Tamanyo" => 90283 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">ROC curves for MR-proANP, copeptin and PCT for mortality risk score prediction. The areas under the ROC curve were: 0.842 (95% CI: 0.744–0.941) for PCT, 0.764 (95% CI: 0.674–0.854) for MR-proANP and 0.735 (95% CI: 0.642–0.827) for copeptin. The differences between markers were not statistically significant (MR-proANP vs PCT, <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.23; MR-proANP vs copeptin, <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.64; PCT vs copeptin, <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.14).</p>" ] ] 3 => array:7 [ "identificador" => "fig0020" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 1563 "Ancho" => 1468 "Tamanyo" => 94225 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">ROC curves for MR-proANP, copeptin and PCT for the prediction of the number of organ system failures. The areas under the ROC curve were: 0.804 (95% CI: 0.715–0.892) for PCT, 0.837 (95% CI: 0.784–0.891) for MR-proANP and 0.735 (95% CI: 0.666–0.804) for copeptin. The difference between MR-proANP and copeptin was significant (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.01). There were no significant differences between MR-proANP and PCT (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.48) and between PCT and copeptin (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.21).</p>" ] ] 4 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">PRISM III and PIM 2 are expressed as mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>standard deviation, diagnosis at admission as absolute frequency and percentage, and the rest of the variables as median (range).</p><p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Group A: group with highest mortality risk scores; Group B: group with lower mortality risk scores.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Total sample<br>(<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>254) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Group A<br>(<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>33) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Group B<br>(<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>221) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">P</span> \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " colspan="5" align="left" valign="top"><span class="elsevierStyleItalic">Demographic and clinical characteristics</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Age at admission (months) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">44 (0–224) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">19 (0–205) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">45 (0–224) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.012 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Weight (kg) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">15.0 (2.7–87.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">11.0 (3.0–74.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">16.0 (2.7–87.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.005 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Male sex (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">59.1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">60.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">58.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.853 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="5" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="5" align="left" valign="top"><span class="elsevierStyleItalic">Diagnosis at admission</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Postoperative care (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">60 (23.6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (1.7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">59 (98.7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Heart surgery (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">47 (18.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">21 (44.7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">26 (55.3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.560 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Respiratory (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">45 (17.7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (2.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">44 (97.8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Infectious (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">40 (15.7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5 (12.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">35 (87.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Trauma (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">17 (6.7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 (11.8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">15 (88.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.002 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Neurologic (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10 (3.9) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10 (100) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 (0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Metabolic-renal (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">9 (3.6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (11.1) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8 (88.9) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.039 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Other (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">26 (16.8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 (7.7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">24 (92.3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>PRISM III<br>(score) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>5.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">15.3<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>6.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>3.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>PIM 2 (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.8<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>7.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">11.2<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>18.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1261710.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Demographic and clinical characteristics.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:39 [ 0 => array:3 [ "identificador" => "bib0200" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognostic indexes of mortality in pediatric intensive care units" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S. Prieto Espuñes" 1 => "J. López-Herce Cid" 2 => "C. Rey Galán" 3 => "A. Medina Villanueva" 4 => "A. Concha Torre" 5 => "P. Martínez Camblor" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "An Pediatr (Barc)" "fecha" => "2007" "volumen" => "66" "paginaInicial" => "345" "paginaFinal" => "350" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0205" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Review of the methodologies and applications of scoring systems in neonatal and pediatric intensive care" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.P. Marcin" 1 => "M.M. Pollack" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Pediatr Crit Care Med" "fecha" => "2000" "volumen" => "1" "paginaInicial" => "20" "paginaFinal" => "27" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12813281" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0210" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "PRISM III: an updated pediatric risk of mortality score" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.M. Pollack" 1 => "K.M. Patel" 2 => "U.E. Ruttimann" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Crit Care Med" "fecha" => "1996" "volumen" => "24" "paginaInicial" => "743" "paginaFinal" => "752" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8706448" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0215" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The suitability of the Pediatric Index of Mortality (PIM), PIM2, the Pediatric Risk of Mortality (PRISM), and PRISM III for monitoring the quality of pediatric intensive care in Australia and New Zealand" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Slater" 1 => "F. Shann" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.PCC.0000138557.31831.65" "Revista" => array:6 [ "tituloSerie" => "Pediatr Crit Care Med" "fecha" => "2004" "volumen" => "5" "paginaInicial" => "447" "paginaFinal" => "454" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15329160" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0220" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Performance of PRISM III and PELOD-2 scores in a pediatric intensive care unit" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J.-P. Gonçalves" 1 => "M. Severo" 2 => "C. Rocha" 3 => "J. Jardim" 4 => "T. Mota" 5 => "A. Ribeiro" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00431-015-2533-5" "Revista" => array:6 [ "tituloSerie" => "Eur J Pediatr" "fecha" => "2015" "volumen" => "174" "paginaInicial" => "1305" "paginaFinal" => "1310" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25875250" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0225" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Enguix" 1 => "C. Rey" 2 => "A. Concha" 3 => "A. Medina" 4 => "D. Coto" 5 => "M.A. Diéguez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Intensive Care Med" "fecha" => "2001" "volumen" => "27" "paginaInicial" => "211" "paginaFinal" => "215" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11280637" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0230" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Rey" 1 => "A.M. Los" 2 => "A. Concha" 3 => "A. Medina" 4 => "S. Prieto" 5 => "P. Martínez-Camblor" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00134-006-0509-7" "Revista" => array:6 [ "tituloSerie" => "Intensive Care Med" "fecha" => "2007" "volumen" => "33" "paginaInicial" => "477" "paginaFinal" => "484" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17260130" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0235" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pro-adrenomedullin, pro-endothelin-1, procalcitonin, C-reactive protein and mortality risk in critically ill children: a prospective study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Rey" 1 => "I. García-Hernández" 2 => "A. Concha" 3 => "P. Martínez-Camblor" 4 => "M. Botrán" 5 => "A. Medina" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/cc13064" "Revista" => array:5 [ "tituloSerie" => "Crit Care" "fecha" => "2013" "volumen" => "17" "paginaInicial" => "R240" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24131732" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0240" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "N.G. Morgenthaler" 1 => "J. Struck" 2 => "M. Christ-Crain" 3 => "A. Bergmann" 4 => "B. Müller" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/cc3015" "Revista" => array:6 [ "tituloSerie" => "Crit Care" "fecha" => "2005" "volumen" => "9" "paginaInicial" => "R37" "paginaFinal" => "R45" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15693965" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0245" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pro-atrial natriuretic peptide (pro-ANP) level in patients with severe sepsis and septic shock: prognostic and diagnostic significance" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M. Lipinska-Gediga" 1 => "M. Mierzchala" 2 => "G. Durek" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s15010-011-0235-0" "Revista" => array:6 [ "tituloSerie" => "Infection" "fecha" => "2012" "volumen" => "40" "paginaInicial" => "303" "paginaFinal" => "309" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22237469" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0250" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Boeck" 1 => "P. Eggimann" 2 => "N. Smyrnios" 3 => "H. Pargger" 4 => "N. Thakkar" 5 => "M. Siegemund" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.00023810" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2011" "volumen" => "37" "paginaInicial" => "595" "paginaFinal" => "603" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20530040" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0255" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Nowak" 1 => "T. Breidthardt" 2 => "M. Christ-Crain" 3 => "R. Bingisser" 4 => "C. Meune" 5 => "Y. Tanglay" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.11-0824" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2012" "volumen" => "141" "paginaInicial" => "974" "paginaFinal" => "982" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22135381" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0260" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "N.G. Morgenthaler" 1 => "B. Müller" 2 => "J. Struck" 3 => "A. Bergmann" 4 => "H. Redl" 5 => "M. Christ-Crain" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/SHK.0b013e318033e5da" "Revista" => array:6 [ "tituloSerie" => "Shock" "fecha" => "2007" "volumen" => "28" "paginaInicial" => "219" "paginaFinal" => "226" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17515850" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0265" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relationship between plasma copeptin levels and complications of community-acquired pneumonia in preschool children" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J.-M. Du" 1 => "G. Sang" 2 => "C.-M. Jiang" 3 => "X.-J. He" 4 => "Y. Han" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Peptides" "fecha" => "2013" "volumen" => "45C" "paginaInicial" => "61" "paginaFinal" => "65" ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0270" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Biomarkers to improve diagnostic and prognostic accuracy in systemic infections" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P. Schuetz" 1 => "M. Christ-Crain" 2 => "B. Muller" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MCC.0b013e3282c9ac2a" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Crit Care" "fecha" => "2007" "volumen" => "13" "paginaInicial" => "578" "paginaFinal" => "585" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17762239" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0275" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Copeptin and arginine vasopressin concentrations in critically ill patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Jochberger" 1 => "N.G. Morgenthaler" 2 => "V.D. Mayr" 3 => "G. Luckner" 4 => "V. Wenzel" 5 => "H. Ulmer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2005-2830" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2006" "volumen" => "91" "paginaInicial" => "4381" "paginaFinal" => "4386" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16940457" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0280" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Natriuretic peptides" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "E.R. Levin" 1 => "D.G. Gardner" 2 => "W.K. Samson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM199807303390507" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1998" "volumen" => "339" "paginaInicial" => "321" "paginaFinal" => "328" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9682046" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0285" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of natriuretic peptides in cardioprotection" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "T. Nishikimi" 1 => "N. Maeda" 2 => "H. Matsuoka" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cardiores.2005.10.001" "Revista" => array:6 [ "tituloSerie" => "Cardiovasc Res" "fecha" => "2006" "volumen" => "69" "paginaInicial" => "318" "paginaFinal" => "328" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16289003" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0290" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "K. Itoi" 1 => "Y.Q. Jiang" 2 => "Y. Iwasaki" 3 => "S.J. Watson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.0953-8194.2004.01172.x" "Revista" => array:6 [ "tituloSerie" => "J Neuroendocrinol" "fecha" => "2004" "volumen" => "16" "paginaInicial" => "348" "paginaFinal" => "355" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15089973" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0295" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Catecholamines and vasopressin during critical illness" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "P. Asfar" 1 => "B. Hauser" 2 => "P. Radermacher" 3 => "M. Matejovic" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Endocrinol Metab Clin N Am" "fecha" => "2006" "volumen" => "35" "paginaInicial" => "839" "paginaFinal" => "857" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0300" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Copeptin and cardiovascular disease: a review of a novel neurohormone" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "K. Yalta" 1 => "T. Yalta" 2 => "N. Sivri" 3 => "E. Yetkin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ijcard.2012.12.039" "Revista" => array:6 [ "tituloSerie" => "Int J Cardiol" "fecha" => "2013" "volumen" => "167" "paginaInicial" => "1750" "paginaFinal" => "1759" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23298558" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0305" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Katan" 1 => "N. Morgenthaler" 2 => "I. Widmer" 3 => "J.J. Puder" 4 => "C. König" 5 => "B. Müller" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Neuro Endocrinol Lett" "fecha" => "2008" "volumen" => "29" "paginaInicial" => "341" "paginaFinal" => "346" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18580851" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0310" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vasopressin and copeptin levels in children with sepsis and septic shock" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.H. Lee" 1 => "Y.H. Chan" 2 => "O.F. Lai" 3 => "J. Puthucheary" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00134-013-2825-z" "Revista" => array:6 [ "tituloSerie" => "Intensive Care Med" "fecha" => "2013" "volumen" => "39" "paginaInicial" => "747" "paginaFinal" => "753" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23344831" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0315" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Copeptin a new and promising diagnostic and prognostic marker" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M. Katan" 1 => "B. Müller" 2 => "M. Christ-Crain" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/cc6799" "Revista" => array:5 [ "tituloSerie" => "Crit Care" "fecha" => "2008" "volumen" => "12" "paginaInicial" => "117" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18355399" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0320" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B. Muller" 1 => "N. Morgenthaler" 2 => "D. Stolz" 3 => "P. Schuetz" 4 => "C. Muller" 5 => "R. Bingisser" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2362.2007.01762.x" "Revista" => array:6 [ "tituloSerie" => "Eur J Clin Invest" "fecha" => "2007" "volumen" => "37" "paginaInicial" => "145" "paginaFinal" => "152" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17217381" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0325" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "N.G. Morgenthaler" 1 => "J. Struck" 2 => "C. Alonso" 3 => "A. Bergmann" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1373/clinchem.2005.060038" "Revista" => array:6 [ "tituloSerie" => "Clin Chem" "fecha" => "2006" "volumen" => "52" "paginaInicial" => "112" "paginaFinal" => "119" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16269513" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0330" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "B. Goldstein" 1 => "B. Giroir" 2 => "A. Randolph" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.PCC.0000149131.72248.E6" "Revista" => array:6 [ "tituloSerie" => "Pediatr Crit Care Med" "fecha" => "2005" "volumen" => "6" "paginaInicial" => "2" "paginaFinal" => "8" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15636651" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0335" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Area under the ROC curve comparison in the presence of missing data" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "P. Martínez-Camblor" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Korean Stat Soc" "fecha" => "2013" "volumen" => "42" "paginaInicial" => "431" "paginaFinal" => "442" ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0340" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prediction about severity and outcome of sepsis by pro-atrial natriuretic peptide and pro-adrenomedullin" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R. Wang" 1 => "F. Kang" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chin J Traumatol" "fecha" => "2010" "volumen" => "13" "paginaInicial" => "152" "paginaFinal" => "157" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20515592" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0345" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Proatrial natriuretic peptide is a better predictor of 28-day mortality in septic shock patients than proendothelin-1" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Guignant" 1 => "F. Venet" 2 => "N. Voirin" 3 => "F. Poitevin" 4 => "C. Malcus" 5 => "J. Bohé" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1515/CCLM.2010.341" "Revista" => array:6 [ "tituloSerie" => "Clin Chem Lab Med" "fecha" => "2010" "volumen" => "48" "paginaInicial" => "1813" "paginaFinal" => "1820" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20704539" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0350" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Differential secretion of atrial and brain natriuretic peptide in critically ill patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "E. Berendes" 1 => "H. van Aken" 2 => "C. Raufhake" 3 => "C. Schmidt" 4 => "G. Assmann" 5 => "M. Walter" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "2001" "volumen" => "93" "paginaInicial" => "676" "paginaFinal" => "682" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11524340" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0355" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R. Seligman" 1 => "J. Papassotiriou" 2 => "N.G. Morgenthaler" 3 => "M. Meisner" 4 => "P.J.Z. Teixeira" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/cc6780" "Revista" => array:5 [ "tituloSerie" => "Crit Care" "fecha" => "2008" "volumen" => "12" "paginaInicial" => "R11" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18252006" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0360" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Plasma copeptin concentration and outcome after pediatric traumatic brain injury" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C. Lin" 1 => "N. Wang" 2 => "Shen Z.-P." 3 => "Z.-Y. Zhao" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Peptides" "fecha" => "2013" "volumen" => "42C" "paginaInicial" => "43" "paginaFinal" => "47" ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0365" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Procalcitonin increase in early identification of critically ill patients at high risk of mortality" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J.U. Jensen" 1 => "L. Heslet" 2 => "T.H. Jensen" 3 => "K. Espersen" 4 => "P. Steffensen" 5 => "M. Tvede" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.CCM.0000239116.01855.61" "Revista" => array:6 [ "tituloSerie" => "Crit Care Med" "fecha" => "2006" "volumen" => "34" "paginaInicial" => "2596" "paginaFinal" => "2602" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16915118" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0370" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Procalcitonin is persistently increased among children with poor outcome from bacterial sepsis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Y.Y. Han" 1 => "L.A. Doughty" 2 => "D. Kofos" 3 => "H. Sasser" 4 => "J.A. Carcillo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.PCC.0000043316.26369.57" "Revista" => array:6 [ "tituloSerie" => "Pediatr Crit Care Med" "fecha" => "2003" "volumen" => "4" "paginaInicial" => "21" "paginaFinal" => "25" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12656537" "web" => "Medline" ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0375" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. Seligman" 1 => "M. Meisner" 2 => "T.C. Lisboa" 3 => "F.T. Hertz" 4 => "T.B. Filippin" 5 => "J.M. Fachel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/cc5036" "Revista" => array:5 [ "tituloSerie" => "Crit Care" "fecha" => "2006" "volumen" => "10" "paginaInicial" => "R125" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16956405" "web" => "Medline" ] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0380" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Procalcitonin as an early indicator of outcome in sepsis: a prospective observational study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E.J. Giamarellos-Bourboulis" 1 => "I. Tsangaris" 2 => "T. Kanni" 3 => "M. Mouktaroudi" 4 => "I. Pantelidou" 5 => "G. Adamis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhin.2010.07.026" "Revista" => array:6 [ "tituloSerie" => "J Hosp Infect" "fecha" => "2011" "volumen" => "77" "paginaInicial" => "58" "paginaFinal" => "63" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21131099" "web" => "Medline" ] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0385" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B.M. Rau" 1 => "I. Frigerio" 2 => "M.W. Büchler" 3 => "K. Wegscheider" 4 => "C. Bassi" 5 => "P.A. Puolakkainen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archsurg.142.2.134" "Revista" => array:6 [ "tituloSerie" => "Arch Surg" "fecha" => "2007" "volumen" => "142" "paginaInicial" => "134" "paginaFinal" => "142" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17309964" "web" => "Medline" ] ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0390" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adrenomedullin is a useful biomarker for the prognosis of critically ill septic children" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "I. Jordan" 1 => "P. Corniero" 2 => "M. Balaguer" 3 => "J. Ortiz" 4 => "D. Vila" 5 => "J. Velasco" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2217/bmm.14.77" "Revista" => array:6 [ "tituloSerie" => "Biomark Med" "fecha" => "2014" "volumen" => "8" "paginaInicial" => "1065" "paginaFinal" => "1072" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25402577" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:3 [ "titulo" => "Acknowledgments" "texto" => "<p id="par0120" class="elsevierStylePara elsevierViewall">We want to thank the medical and nursing staff of the PICUs of the Hospital Universitario Central de Asturias and the Hospital Universitario Gregorio Marañón, as well as the staff of the Department of Biochemistry of the Hospital Universitario Central de Asturias.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/23412879/0000008500000006/v1_201611291247/S234128791630120X/v1_201611291247/en/main.assets" "Apartado" => array:4 [ "identificador" => "26005" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original Articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23412879/0000008500000006/v1_201611291247/S234128791630120X/v1_201611291247/en/main.pdf?idApp=UINPBA00005H&text.app=https://analesdepediatria.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S234128791630120X?idApp=UINPBA00005H" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 7 | 9 | 16 |
2024 October | 37 | 39 | 76 |
2024 September | 37 | 38 | 75 |
2024 August | 48 | 62 | 110 |
2024 July | 40 | 37 | 77 |
2024 June | 46 | 31 | 77 |
2024 May | 48 | 24 | 72 |
2024 April | 46 | 27 | 73 |
2024 March | 46 | 25 | 71 |
2024 February | 46 | 32 | 78 |
2024 January | 31 | 29 | 60 |
2023 December | 51 | 23 | 74 |
2023 November | 47 | 24 | 71 |
2023 October | 36 | 32 | 68 |
2023 September | 23 | 20 | 43 |
2023 August | 36 | 16 | 52 |
2023 July | 31 | 26 | 57 |
2023 June | 40 | 31 | 71 |
2023 May | 40 | 23 | 63 |
2023 April | 24 | 15 | 39 |
2023 March | 55 | 26 | 81 |
2023 February | 33 | 17 | 50 |
2023 January | 21 | 18 | 39 |
2022 December | 55 | 22 | 77 |
2022 November | 62 | 39 | 101 |
2022 October | 56 | 36 | 92 |
2022 September | 26 | 29 | 55 |
2022 August | 35 | 49 | 84 |
2022 July | 31 | 37 | 68 |
2022 June | 25 | 33 | 58 |
2022 May | 42 | 32 | 74 |
2022 April | 26 | 22 | 48 |
2022 March | 39 | 51 | 90 |
2022 February | 28 | 24 | 52 |
2022 January | 32 | 33 | 65 |
2021 December | 23 | 39 | 62 |
2021 November | 40 | 41 | 81 |
2021 October | 64 | 90 | 154 |
2021 September | 31 | 28 | 59 |
2021 August | 27 | 42 | 69 |
2021 July | 19 | 25 | 44 |
2021 June | 25 | 39 | 64 |
2021 May | 35 | 51 | 86 |
2021 April | 94 | 84 | 178 |
2021 March | 54 | 33 | 87 |
2021 February | 28 | 24 | 52 |
2021 January | 31 | 21 | 52 |
2020 December | 33 | 27 | 60 |
2020 November | 23 | 14 | 37 |
2020 October | 22 | 16 | 38 |
2020 September | 31 | 15 | 46 |
2020 August | 11 | 14 | 25 |
2020 July | 45 | 22 | 67 |
2020 June | 27 | 17 | 44 |
2020 May | 19 | 17 | 36 |
2020 April | 23 | 10 | 33 |
2020 March | 29 | 14 | 43 |
2020 February | 24 | 19 | 43 |
2020 January | 10 | 8 | 18 |
2019 December | 58 | 25 | 83 |
2019 November | 8 | 5 | 13 |
2019 October | 28 | 18 | 46 |
2019 September | 22 | 9 | 31 |
2019 August | 57 | 23 | 80 |
2019 July | 33 | 16 | 49 |
2019 June | 31 | 19 | 50 |
2019 May | 32 | 24 | 56 |
2019 April | 68 | 33 | 101 |
2019 March | 40 | 13 | 53 |
2019 February | 39 | 12 | 51 |
2019 January | 37 | 21 | 58 |
2018 December | 57 | 25 | 82 |
2018 November | 55 | 37 | 92 |
2018 October | 68 | 18 | 86 |
2018 September | 20 | 20 | 40 |
2018 July | 2 | 0 | 2 |
2018 June | 6 | 0 | 6 |
2018 May | 3 | 0 | 3 |
2018 April | 25 | 0 | 25 |
2018 March | 25 | 0 | 25 |
2018 February | 12 | 0 | 12 |
2018 January | 11 | 0 | 11 |
2017 December | 21 | 0 | 21 |
2017 November | 27 | 0 | 27 |
2017 October | 27 | 0 | 27 |
2017 September | 24 | 0 | 24 |
2017 August | 18 | 0 | 18 |
2017 July | 13 | 0 | 13 |
2017 June | 15 | 5 | 20 |
2017 May | 18 | 6 | 24 |
2017 April | 9 | 6 | 15 |
2017 March | 9 | 5 | 14 |
2017 February | 12 | 6 | 18 |
2017 January | 13 | 3 | 16 |
2016 December | 40 | 19 | 59 |
2016 November | 0 | 18 | 18 |